Quick Answer
Propanc Biopharma, Inc. reported Stockholders Equity of $13.91 million for fiscal year 2025.
Propanc Biopharma, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $13.91M | +468.0% |
| 2024 | -$3.78M | -21.2% |
| 2023 | -$3.12M | -3.1% |
| 2022 | -$3.02M | +1.4% |
| 2021 | -$3.07M | +15.8% |
| 2020 | -$3.64M | +15.3% |
| 2019 | -$4.30M | +36.3% |
| 2018 | -$6.75M | -24.1% |
| 2017 | -$5.44M | -112.1% |
| 2016 | -$2.57M | +16.0% |
| 2015 | -$3.05M | -116.8% |
| 2014 | -$1.41M | -77.7% |
| 2013 | -$792.5K | -47.3% |
| 2012 | -$537.9K | -105.1% |
| 2011 | $10.51M | +5721.8% |
| 2010 | -$186.9K | +54.3% |
| 2009 | -$409.4K | -580.9% |
| 2008 | $85.1K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $10.45M | +351.3% | -27.2% |
| September 30, 2025 | $14.36M | +449.6% | +3.3% |
| June 30, 2025 | $13.91M | +468.0% | -23.1% |
| March 31, 2025 | $18.09M | +589.0% | +535.0% |
| December 31, 2024 | -$4.16M | -16.7% | -1.2% |
| September 30, 2024 | -$4.11M | -37.4% | -8.7% |
| June 30, 2024 | -$3.78M | -21.2% | -2.2% |
| March 31, 2024 | -$3.70M | -25.8% | -3.8% |
- Propanc Biopharma, Inc. showed an increase of +468.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, Propanc Biopharma, Inc.’s stockholders equity has grown by 16234.5% (from $85.1 thousand to $13.91 million).
- The most recent figure is from Propanc Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: